Hebei Joycome Pharmaceutical Co., Ltd. ne a dabbobi Pharmaceutical samfurin ci gaba da kuma masana'antu kamfanin kafa a 2000 a Shijiazhuang Hebei lardin, tare da rajista babban birnin kasar Yuan miliyan 50.Mayar da hankali da burinmu shine samar da abokan ciniki da samfuran da ke haɓaka kiwon lafiyar dabbobi, kaji da abokan hulɗa.
Mun fahimci yadda kowane dabba yake da daraja ga mai shi da kuma lokacin da dabba ta sha wahala, mai kula da su yana raba raɗaɗi.An tsara magungunan mu na dabbobi a hankali don inganta lafiyar dabbobi da jin daɗin rayuwa.
Dangane da fiye da shekaru 20 na gogewa, tare da sabuntawa akai-akai da fahimtar takamaiman buƙatun kasuwa, Joycome Pharma yana haɓakawa da kera samfuran samfuran da yawa don saduwa da buƙatun abokan cinikinmu iri-iri a duniya.Muna mai da hankali kan isar da samfuran inganci da aminci don kiwon kaji, dabbobi, equine da dabbobin dabbobi a cikin nau'ikan magunguna daban-daban: allura, kwamfutar hannu / bolus, foda / premix, mafita na baka, fesa / faduwa, disinfectant, magani na ganye da albarkatun ƙasa.
Kamfanin yana da sansanonin samarwa na 3 GMP tare da kayan aiki na ci gaba da manyan ma'aikatan fasaha.Kamfaninmu ya kiyaye dangantakar hadin gwiwa tare da jami'ar aikin gona ta kasar Sin, jami'ar aikin gona ta Hebei, jami'ar aikin gona ta Nanjing da cibiyoyin bincike na kimiyya da yawa.Ya zuwa yanzu mun ayyana ayyukan kimiyya da fasaha na kasa guda 8 kuma mun sami damar mallakar haƙƙin mallaka na ƙasa guda 16 da 5 na musamman na fasaha.
Domin samun tare da sauri da kuma mafi kyau ci gaban mu sabon high misali morden factory da yanki na 20,000 murabba'in mita za a sa a cikin aiki a 2022.The sabon factory is located in Nanhe gundumar, Xingtai Hebei lardin, daya daga cikin mafi girma Pharmaceutical da kuma dabbobi. tushe masana'antu a kasar Sin.A halin yanzu, Joycome Pharma ta zama kamfani mafi girma cikin sauri a masana'antar kiwon lafiyar dabbobi a lardin Hebei.
Ingancin, ƙirƙira da ƙwararren sabis ga abokan cinikinmu a duk duniya a cikin masana'antar kiwon lafiyar dabbobi.
